ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,563Medicare Part D Prescriptions Filled, Including Refills

Rank: 382 out of 1454

$589K Total Retail Price of All Prescriptions

Rank: 329 out of 1454

419 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 351 307 1 3
SIMVASTATIN 334 300 2 1
DONEPEZIL HCL 318 312 3 29
AMLODIPINE BESYLATE 289 265 4 2
FUROSEMIDE 284 245 5 6
NAMENDA 253 252 6 48
LEVOTHYROXINE SODIUM 249 191 7 5
LISINOPRIL 224 186 8 4
CITALOPRAM HBR 199 184 9 21
NOVOLOG 169 133 10 99
METOPROLOL TARTRATE 168 142 11 10
TRAMADOL HCL 160 122 12 20
DIVALPROEX SODIUM 153 131 13 106
MIRTAZAPINE 151 143 14 53
ALENDRONATE SODIUM 149 149 15 35
METFORMIN HCL 136 109 16 8
HYDROCODONE-ACETAMINOPHEN 132 108 S3 17 7
GABAPENTIN 126 85 18 16
POTASSIUM CHLORIDE 125 107 19 15
LANTUS 123 92 20 51
METOPROLOL SUCCINATE 118 118 21 13
LEVETIRACETAM 100 76 22 114
SERTRALINE HCL 97 79 23 26
HYDROCHLOROTHIAZIDE 96 75 24 9
SEROQUEL 95 81 25 177
ZOLPIDEM TARTRATE 95 75 25 19
KLOR-CON M20 94 77 27 54
CYMBALTA 92 75 28 55
HYDRALAZINE HCL 90 85 29 67
CRESTOR 84 58 30 22
ALLOPURINOL 83 78 31 28
CLONIDINE HCL 79 53 32 49
CARVEDILOL 79 70 32 24
ISOSORBIDE MONONITRATE ER 79 64 32 46
LOSARTAN POTASSIUM 77 55 35 14
ESCITALOPRAM OXALATE 75 49 36 78
CLONIDINE 66 65 37 252
FLUTICASONE PROPIONATE 64 53 38 30
QUETIAPINE FUMARATE 61 55 39 91
ADVAIR DISKUS 57 50 40 47
POLYETHYLENE GLYCOL 3350 57 40 40 61
KLOR-CON M10 57 46 40 145
WARFARIN SODIUM 55 15 43 17
FENTANYL 55 28 S2 43 104
TRAZODONE HCL 54 33 45 50
NEXIUM 52 39 46 23
PANTOPRAZOLE SODIUM 50 47 47 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.